JP2004507533A - 二環式複素環化合物、これらの化合物を含む医薬組成物、それらの使用及びその生成方法 - Google Patents
二環式複素環化合物、これらの化合物を含む医薬組成物、それらの使用及びその生成方法 Download PDFInfo
- Publication number
- JP2004507533A JP2004507533A JP2002523885A JP2002523885A JP2004507533A JP 2004507533 A JP2004507533 A JP 2004507533A JP 2002523885 A JP2002523885 A JP 2002523885A JP 2002523885 A JP2002523885 A JP 2002523885A JP 2004507533 A JP2004507533 A JP 2004507533A
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- substituted
- oxo
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10042061A DE10042061A1 (de) | 2000-08-26 | 2000-08-26 | Bicyclische Heterocyclen,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
PCT/EP2001/009535 WO2002018370A1 (de) | 2000-08-26 | 2001-08-18 | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2004507533A true JP2004507533A (ja) | 2004-03-11 |
Family
ID=7653948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002523885A Pending JP2004507533A (ja) | 2000-08-26 | 2001-08-18 | 二環式複素環化合物、これらの化合物を含む医薬組成物、それらの使用及びその生成方法 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1315716A1 (de) |
JP (1) | JP2004507533A (de) |
AU (1) | AU2001289814A1 (de) |
CA (1) | CA2417042A1 (de) |
DE (1) | DE10042061A1 (de) |
MX (1) | MXPA03001510A (de) |
WO (1) | WO2002018370A1 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013528189A (ja) * | 2010-06-09 | 2013-07-08 | 天津和美生物技術有限公司 | シアノキノリン誘導体 |
JP2013536253A (ja) * | 2010-08-30 | 2013-09-19 | 山東軒竹医薬科技有限公司 | アニリンで置換されたキナゾリン誘導体、その調製方法及びその使用 |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200813014A (en) | 2002-03-28 | 2008-03-16 | Astrazeneca Ab | Quinazoline derivatives |
US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
DE10217689A1 (de) * | 2002-04-19 | 2003-11-13 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
US20040044014A1 (en) | 2002-04-19 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
WO2006074147A2 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics, Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
GB0317665D0 (en) | 2003-07-29 | 2003-09-03 | Astrazeneca Ab | Qinazoline derivatives |
ES2279441T3 (es) | 2003-09-19 | 2007-08-16 | Astrazeneca Ab | Derivados de quinazolina. |
US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
TW200640904A (en) | 2005-02-26 | 2006-12-01 | Astrazeneca Ab | Quinazoline derivatives |
EP1921070A1 (de) | 2006-11-10 | 2008-05-14 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung |
WO2008095847A1 (de) | 2007-02-06 | 2008-08-14 | Boehringer Ingelheim International Gmbh | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
WO2009098061A1 (de) | 2008-02-07 | 2009-08-13 | Boehringer Ingelheim International Gmbh | Spirocyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
AU2009247782C1 (en) | 2008-05-13 | 2013-09-19 | Astrazeneca Ab | Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (N-methylcarbamoylmethyl) piperidin- 4-yl] oxy } quinazoline |
JP5539351B2 (ja) | 2008-08-08 | 2014-07-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | シクロヘキシルオキシ置換ヘテロ環、これらの化合物を含有する医薬、およびそれらを生成するための方法 |
TWI385174B (zh) | 2008-11-10 | 2013-02-11 | Nat Health Research Institutes | 作為酪胺酸激酶抑制劑之稠合雙環及多環嘧啶化合物 |
KR101317809B1 (ko) | 2011-06-07 | 2013-10-16 | 한미약품 주식회사 | 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물 |
KR20140096571A (ko) | 2013-01-28 | 2014-08-06 | 한미약품 주식회사 | 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법 |
AU2019346550A1 (en) | 2018-09-25 | 2021-04-22 | Black Diamond Therapeutics, Inc. | Quinazoline derivatives as tyrosine kinase inhibitor, compositions, methods of making them and their use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9718972D0 (en) * | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
-
2000
- 2000-08-26 DE DE10042061A patent/DE10042061A1/de not_active Withdrawn
-
2001
- 2001-08-18 AU AU2001289814A patent/AU2001289814A1/en not_active Abandoned
- 2001-08-18 CA CA002417042A patent/CA2417042A1/en not_active Abandoned
- 2001-08-18 JP JP2002523885A patent/JP2004507533A/ja active Pending
- 2001-08-18 EP EP01969610A patent/EP1315716A1/de not_active Withdrawn
- 2001-08-18 MX MXPA03001510A patent/MXPA03001510A/es unknown
- 2001-08-18 WO PCT/EP2001/009535 patent/WO2002018370A1/de not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013528189A (ja) * | 2010-06-09 | 2013-07-08 | 天津和美生物技術有限公司 | シアノキノリン誘導体 |
JP2013536253A (ja) * | 2010-08-30 | 2013-09-19 | 山東軒竹医薬科技有限公司 | アニリンで置換されたキナゾリン誘導体、その調製方法及びその使用 |
US9730934B2 (en) | 2010-08-30 | 2017-08-15 | Xuanzhu Pharma Co., Ltd. | Quinazoline derivatives substituted by aniline, preparation method and use thereof |
US10507209B2 (en) | 2010-08-30 | 2019-12-17 | Xuanzhu Pharma Co, Ltd. | Quinazoline derivatives substituted by aniline, preparation method and use thereof |
Also Published As
Publication number | Publication date |
---|---|
CA2417042A1 (en) | 2002-03-07 |
AU2001289814A1 (en) | 2002-03-13 |
EP1315716A1 (de) | 2003-06-04 |
DE10042061A1 (de) | 2002-03-07 |
MXPA03001510A (es) | 2003-06-09 |
WO2002018370A1 (de) | 2002-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4901055B2 (ja) | 二環系ヘテロ環、これらの化合物を含有する医薬組成物、それらの使用及びそれらの調製法 | |
JP3754617B2 (ja) | 二環式複素環化合物、その化合物を含む医薬組成物、及び製法 | |
JP4834282B2 (ja) | 二環式複素環、それを含む医薬組成物、その使用及びその製造方法 | |
US20020082270A1 (en) | Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases | |
JP3686610B2 (ja) | 二環式複素環化合物、その化合物を含む医薬組成物、使用及び調製方法 | |
US6740651B2 (en) | Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases | |
JP2004507533A (ja) | 二環式複素環化合物、これらの化合物を含む医薬組成物、それらの使用及びその生成方法 | |
JP4939716B2 (ja) | 二環式複素環化合物、これらの化合物を含む医薬組成物、それらの使用及びそれらの調製方法 | |
US6627634B2 (en) | Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them | |
JP3751201B2 (ja) | チロシンキナーゼにより媒介されるシグナル伝達に関する抑制効果を有する4−アミノ−キナゾリン誘導体及びキノリン誘導体 | |
US6617329B2 (en) | Aminoquinazolines and their use as medicaments | |
JP2004507538A (ja) | 二環式複素環化合物、これらの化合物を含む薬剤、それらの使用、及びその生成方法 | |
JP2004517048A (ja) | キナゾリン誘導体、これらの化合物を含む医薬組成物、それらの使用及びそれらの調製方法 | |
US20060063752A1 (en) | Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them | |
EA009300B1 (ru) | 4-(n-фениламино)хиназолины/-хинолины в качестве ингибиторов тирозинкиназы | |
JP4527406B2 (ja) | 二環式ヘテロ環化合物、これら化合物を含有する医薬組成物、その使用及びその製造方法 | |
JP5377332B2 (ja) | 二環式へテロ環、それらの化合物を含む薬剤、その使用及びその製法 | |
JP2006527176A (ja) | 二環式複素環化合物、該化合物を含む医薬品、その使用と製造方法 | |
JP2002539214A (ja) | 二環式複素環化合物、その化合物を含む医薬組成物、その使用及び調製方法 | |
JP2004507537A (ja) | キナゾリン化合物、この化合物を含有する医薬組成物、その使用及びその調製方法 | |
TWI230156B (en) | Quinazoline compounds with inhibitory activity on signal transduction mediated by tyrosine kinases, pharmaceutical compositions containing these compounds and their use |